Ischemia Reperfusion Injury Industry Research Report 2024

Ischemia Reperfusion Injury Industry Research Report 2024


Reperfusion injury or reperfusion insult, sometimes called ischemia-reperfusion injury (IRI) or reoxygenation injury, is the tissue damage caused when blood supply returns to tissue (re- + perfusion) after a period of ischemia or lack of oxygen (anoxia or hypoxia). The absence of oxygen and nutrients from blood during the ischemic period creates a condition in which the restoration of circulation results in inflammation and oxidative damage through the induction of oxidative stress rather than (or along with) restoration of normal function.

Highlights

The global Ischemia Reperfusion Injury market is projected to reach US$ million by 2030 from an estimated US$ million in 2024, at a CAGR of % during 2025 and 2030.
Global Ischemia Reperfusion Injury key players include Angion Biomedica, Catalyst Biosciences, Ischemix Inc, etc.
North America is the largest market, with a share about 50%, followed by Europe, and Japan, both have a share over 20 percent.
In terms of product, Phase 2 is the largest segment, with a share about 40%. And in terms of application, the largest application is Kidney Injury, followed by Heart Injury, Intestine Injury, etc.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Ischemia Reperfusion Injury, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Ischemia Reperfusion Injury.
The Ischemia Reperfusion Injury market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Ischemia Reperfusion Injury market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Ischemia Reperfusion Injury companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue by companies for the period 2019-2024. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:

Angion Biomedica
Catalyst Biosciences
Ischemix Inc
Opsona Therapeutics
Pharming
TheraSource
Bolder Biotechnology
Corline Biomedical
Mifcortx
Balmes Transplantation
NovelMed Therapeutics
Hope Pharmaceuticals
Omeros Corp
Prothix
SBI Pharmaceuticals

Product Type Insights

Global markets are presented by Ischemia Reperfusion Injury type, along with growth forecasts through 2030. Estimates on revenue are based on the price in the supply chain at which the Ischemia Reperfusion Injury are procured by the companies.
This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows revenue data by type, and during the historical period (2019-2024) and forecast period (2025-2030).
Ischemia Reperfusion Injury segment by Type

Phase 1
Phase 2
Preclinical

Application Insights

This report has provided the market size (revenue data) by application, during the historical period (2019-2024) and forecast period (2025-2030).
This report also outlines the market trends of each segment and consumer behaviors impacting the Ischemia Reperfusion Injury market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the Ischemia Reperfusion Injury market.
Ischemia Reperfusion Injury Segment by Application
Heart Injury
Kidney Injury
Intestine Injury
Other Injury

Regional Outlook

This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue data of each region and country for the period 2019-2030.

The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2023 because of the base year, with estimates for 2024 and forecast revenue for 2030.

North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Ischemia Reperfusion Injury market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.

Reasons to Buy This Report

This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Ischemia Reperfusion Injury market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
This report will help stakeholders to understand the global industry status and trends of Ischemia Reperfusion Injury and provides them with information on key market drivers, restraints, challenges, and opportunities.
This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
This report stays updated with novel technology integration, features, and the latest developments in the market
This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Ischemia Reperfusion Injury industry.
This report helps stakeholders to gain insights into which regions to target globally
This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Ischemia Reperfusion Injury.
This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Core Chapters

Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Ischemia Reperfusion Injury companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.


1 Preface
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 Market Overview
2.1 Product Definition
2.2 Ischemia Reperfusion Injury by Type
2.2.1 Market Value Comparison by Type (2019 VS 2023 VS 2030)
1.2.2 Phase 1
1.2.3 Phase 2
1.2.4 Preclinical
2.3 Ischemia Reperfusion Injury by Application
2.3.1 Market Value Comparison by Application (2019 VS 2023 VS 2030)
2.3.2 Heart Injury
2.3.3 Kidney Injury
2.3.4 Intestine Injury
2.3.5 Other Injury
2.4 Assumptions and Limitations
3 Ischemia Reperfusion Injury Breakdown Data by Type
3.1 Global Ischemia Reperfusion Injury Historic Market Size by Type (2019-2024)
3.2 Global Ischemia Reperfusion Injury Forecasted Market Size by Type (2025-2030)
4 Ischemia Reperfusion Injury Breakdown Data by Application
4.1 Global Ischemia Reperfusion Injury Historic Market Size by Application (2019-2024)
4.2 Global Ischemia Reperfusion Injury Forecasted Market Size by Application (2019-2024)
5 Global Growth Trends
5.1 Global Ischemia Reperfusion Injury Market Perspective (2019-2030)
5.2 Global Ischemia Reperfusion Injury Growth Trends by Region
5.2.1 Global Ischemia Reperfusion Injury Market Size by Region: 2019 VS 2023 VS 2030
5.2.2 Ischemia Reperfusion Injury Historic Market Size by Region (2019-2024)
5.2.3 Ischemia Reperfusion Injury Forecasted Market Size by Region (2025-2030)
5.3 Ischemia Reperfusion Injury Market Dynamics
5.3.1 Ischemia Reperfusion Injury Industry Trends
5.3.2 Ischemia Reperfusion Injury Market Drivers
5.3.3 Ischemia Reperfusion Injury Market Challenges
5.3.4 Ischemia Reperfusion Injury Market Restraints
6 Market Competitive Landscape by Players
6.1 Global Top Ischemia Reperfusion Injury Players by Revenue
6.1.1 Global Top Ischemia Reperfusion Injury Players by Revenue (2019-2024)
6.1.2 Global Ischemia Reperfusion Injury Revenue Market Share by Players (2019-2024)
6.2 Global Ischemia Reperfusion Injury Industry Players Ranking, 2022 VS 2023 VS 2024
6.3 Global Key Players of Ischemia Reperfusion Injury Head office and Area Served
6.4 Global Ischemia Reperfusion Injury Players, Product Type & Application
6.5 Global Ischemia Reperfusion Injury Players, Date of Enter into This Industry
6.6 Global Ischemia Reperfusion Injury Market CR5 and HHI
6.7 Global Players Mergers & Acquisition
7 North America
7.1 North America Ischemia Reperfusion Injury Market Size (2019-2030)
7.2 North America Ischemia Reperfusion Injury Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 North America Ischemia Reperfusion Injury Market Size by Country (2019-2024)
7.4 North America Ischemia Reperfusion Injury Market Size by Country (2025-2030)
7.5 United States
7.6 Canada
8 Europe
8.1 Europe Ischemia Reperfusion Injury Market Size (2019-2030)
8.2 Europe Ischemia Reperfusion Injury Market Growth Rate by Country: 2019 VS 2023 VS 2030
8.3 Europe Ischemia Reperfusion Injury Market Size by Country (2019-2024)
8.4 Europe Ischemia Reperfusion Injury Market Size by Country (2025-2030)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
9 Asia-Pacific
9.1 Asia-Pacific Ischemia Reperfusion Injury Market Size (2019-2030)
9.2 Asia-Pacific Ischemia Reperfusion Injury Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Asia-Pacific Ischemia Reperfusion Injury Market Size by Country (2019-2024)
9.4 Asia-Pacific Ischemia Reperfusion Injury Market Size by Country (2025-2030)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
10 Latin America
10.1 Latin America Ischemia Reperfusion Injury Market Size (2019-2030)
10.2 Latin America Ischemia Reperfusion Injury Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Latin America Ischemia Reperfusion Injury Market Size by Country (2019-2024)
10.4 Latin America Ischemia Reperfusion Injury Market Size by Country (2025-2030)
9.4 Mexico
9.5 Brazil
11 Middle East & Africa
11.1 Middle East & Africa Ischemia Reperfusion Injury Market Size (2019-2030)
11.2 Middle East & Africa Ischemia Reperfusion Injury Market Growth Rate by Country: 2019 VS 2023 VS 2030
11.3 Middle East & Africa Ischemia Reperfusion Injury Market Size by Country (2019-2024)
11.4 Middle East & Africa Ischemia Reperfusion Injury Market Size by Country (2025-2030)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
12 Players Profiled
11.1 Angion Biomedica
11.1.1 Angion Biomedica Company Detail
11.1.2 Angion Biomedica Business Overview
11.1.3 Angion Biomedica Ischemia Reperfusion Injury Introduction
11.1.4 Angion Biomedica Revenue in Ischemia Reperfusion Injury Business (2017-2022)
11.1.5 Angion Biomedica Recent Development
11.2 Catalyst Biosciences
11.2.1 Catalyst Biosciences Company Detail
11.2.2 Catalyst Biosciences Business Overview
11.2.3 Catalyst Biosciences Ischemia Reperfusion Injury Introduction
11.2.4 Catalyst Biosciences Revenue in Ischemia Reperfusion Injury Business (2017-2022)
11.2.5 Catalyst Biosciences Recent Development
11.3 Ischemix Inc
11.3.1 Ischemix Inc Company Detail
11.3.2 Ischemix Inc Business Overview
11.3.3 Ischemix Inc Ischemia Reperfusion Injury Introduction
11.3.4 Ischemix Inc Revenue in Ischemia Reperfusion Injury Business (2017-2022)
11.3.5 Ischemix Inc Recent Development
11.4 Opsona Therapeutics
11.4.1 Opsona Therapeutics Company Detail
11.4.2 Opsona Therapeutics Business Overview
11.4.3 Opsona Therapeutics Ischemia Reperfusion Injury Introduction
11.4.4 Opsona Therapeutics Revenue in Ischemia Reperfusion Injury Business (2017-2022)
11.4.5 Opsona Therapeutics Recent Development
11.5 Pharming
11.5.1 Pharming Company Detail
11.5.2 Pharming Business Overview
11.5.3 Pharming Ischemia Reperfusion Injury Introduction
11.5.4 Pharming Revenue in Ischemia Reperfusion Injury Business (2017-2022)
11.5.5 Pharming Recent Development
11.6 TheraSource
11.6.1 TheraSource Company Detail
11.6.2 TheraSource Business Overview
11.6.3 TheraSource Ischemia Reperfusion Injury Introduction
11.6.4 TheraSource Revenue in Ischemia Reperfusion Injury Business (2017-2022)
11.6.5 TheraSource Recent Development
11.7 Bolder Biotechnology
11.7.1 Bolder Biotechnology Company Detail
11.7.2 Bolder Biotechnology Business Overview
11.7.3 Bolder Biotechnology Ischemia Reperfusion Injury Introduction
11.7.4 Bolder Biotechnology Revenue in Ischemia Reperfusion Injury Business (2017-2022)
11.7.5 Bolder Biotechnology Recent Development
11.8 Corline Biomedical
11.8.1 Corline Biomedical Company Detail
11.8.2 Corline Biomedical Business Overview
11.8.3 Corline Biomedical Ischemia Reperfusion Injury Introduction
11.8.4 Corline Biomedical Revenue in Ischemia Reperfusion Injury Business (2017-2022)
11.8.5 Corline Biomedical Recent Development
11.9 Mifcortx
11.9.1 Mifcortx Company Detail
11.9.2 Mifcortx Business Overview
11.9.3 Mifcortx Ischemia Reperfusion Injury Introduction
11.9.4 Mifcortx Revenue in Ischemia Reperfusion Injury Business (2017-2022)
11.9.5 Mifcortx Recent Development
11.10 Balmes Transplantation
11.10.1 Balmes Transplantation Company Detail
11.10.2 Balmes Transplantation Business Overview
11.10.3 Balmes Transplantation Ischemia Reperfusion Injury Introduction
11.10.4 Balmes Transplantation Revenue in Ischemia Reperfusion Injury Business (2017-2022)
11.10.5 Balmes Transplantation Recent Development
11.11 NovelMed Therapeutics
11.11.1 NovelMed Therapeutics Company Detail
11.11.2 NovelMed Therapeutics Business Overview
11.11.3 NovelMed Therapeutics Ischemia Reperfusion Injury Introduction
11.11.4 NovelMed Therapeutics Revenue in Ischemia Reperfusion Injury Business (2017-2022)
11.11.5 NovelMed Therapeutics Recent Development
11.12 Hope Pharmaceuticals
11.12.1 Hope Pharmaceuticals Company Detail
11.12.2 Hope Pharmaceuticals Business Overview
11.12.3 Hope Pharmaceuticals Ischemia Reperfusion Injury Introduction
11.12.4 Hope Pharmaceuticals Revenue in Ischemia Reperfusion Injury Business (2017-2022)
11.12.5 Hope Pharmaceuticals Recent Development
11.13 Omeros Corp
11.13.1 Omeros Corp Company Detail
11.13.2 Omeros Corp Business Overview
11.13.3 Omeros Corp Ischemia Reperfusion Injury Introduction
11.13.4 Omeros Corp Revenue in Ischemia Reperfusion Injury Business (2017-2022)
11.13.5 Omeros Corp Recent Development
11.14 Prothix
11.14.1 Prothix Company Detail
11.14.2 Prothix Business Overview
11.14.3 Prothix Ischemia Reperfusion Injury Introduction
11.14.4 Prothix Revenue in Ischemia Reperfusion Injury Business (2017-2022)
11.14.5 Prothix Recent Development
11.15 SBI Pharmaceuticals
11.15.1 SBI Pharmaceuticals Company Detail
11.15.2 SBI Pharmaceuticals Business Overview
11.15.3 SBI Pharmaceuticals Ischemia Reperfusion Injury Introduction
11.15.4 SBI Pharmaceuticals Revenue in Ischemia Reperfusion Injury Business (2017-2022)
11.15.5 SBI Pharmaceuticals Recent Development
13 Report Conclusion
14 Disclaimer
List of Tables
Table 1. Secondary Sources
Table 2. Primary Sources
Table 3. Market Value Comparison by Type (2019 VS 2023 VS 2030) & (US$ Million)
Table 4. Market Value Comparison by Application (2019 VS 2023 VS 2030) & (US$ Million)
Table 5. Global Ischemia Reperfusion Injury Market Size by Type (2019-2024) & (US$ Million)
Table 6. Global Ischemia Reperfusion Injury Revenue Market Share by Type (2019-2024)
Table 7. Global Ischemia Reperfusion Injury Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 8. Global Ischemia Reperfusion Injury Revenue Market Share by Type (2025-2030)
Table 9. Global Ischemia Reperfusion Injury Market Size by Application (2019-2024) & (US$ Million)
Table 10. Global Ischemia Reperfusion Injury Revenue Market Share by Application (2019-2024)
Table 11. Global Ischemia Reperfusion Injury Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 12. Global Ischemia Reperfusion Injury Revenue Market Share by Application (2025-2030)
Table 13. Global Ischemia Reperfusion Injury Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 14. Global Ischemia Reperfusion Injury Market Size by Region (2019-2024) & (US$ Million)
Table 15. Global Ischemia Reperfusion Injury Market Share by Region (2019-2024)
Table 16. Global Ischemia Reperfusion Injury Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 17. Global Ischemia Reperfusion Injury Market Share by Region (2025-2030)
Table 18. Ischemia Reperfusion Injury Market Trends
Table 19. Ischemia Reperfusion Injury Market Drivers
Table 20. Ischemia Reperfusion Injury Market Challenges
Table 21. Ischemia Reperfusion Injury Market Restraints
Table 22. Global Top Ischemia Reperfusion Injury Manufacturers by Revenue (US$ Million) & (2019-2024)
Table 23. Global Ischemia Reperfusion Injury Revenue Market Share by Manufacturers (2019-2024)
Table 24. Global Ischemia Reperfusion Injury Industry Manufacturers Ranking, 2022 VS 2023 VS 2024
Table 25. Global Key Players of Ischemia Reperfusion Injury, Headquarters and Area Served
Table 26. Global Ischemia Reperfusion Injury Manufacturers, Product Type & Application
Table 27. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 28. Global Ischemia Reperfusion Injury by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2023)
Table 29. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 30. North America Ischemia Reperfusion Injury Market Growth Rate by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. North America Ischemia Reperfusion Injury Market Size by Country (2019-2024) & (US$ Million)
Table 32. North America Ischemia Reperfusion Injury Market Size by Country (2025-2030) & (US$ Million)
Table 33. Europe Ischemia Reperfusion Injury Market Growth Rate by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 34. Europe Ischemia Reperfusion Injury Market Size by Country (2019-2024) & (US$ Million)
Table 35. Europe Ischemia Reperfusion Injury Market Size by Country (2025-2030) & (US$ Million)
Table 36. Asia-Pacific Ischemia Reperfusion Injury Market Growth Rate by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 37. Asia-Pacific Ischemia Reperfusion Injury Market Size by Country (2019-2024) & (US$ Million)
Table 38. Asia-Pacific Ischemia Reperfusion Injury Market Size by Country (2025-2030) & (US$ Million)
Table 39. Latin America Ischemia Reperfusion Injury Market Growth Rate by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 40. Latin America Ischemia Reperfusion Injury Market Size by Country (2019-2024) & (US$ Million)
Table 41. Latin America Ischemia Reperfusion Injury Market Size by Country (2025-2030) & (US$ Million)
Table 42. Middle East & Africa Ischemia Reperfusion Injury Market Growth Rate by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 43. Middle East & Africa Ischemia Reperfusion Injury Market Size by Country (2019-2024) & (US$ Million)
Table 44. Middle East & Africa Ischemia Reperfusion Injury Market Size by Country (2025-2030) & (US$ Million)
Table 45. Angion Biomedica Company Detail
Table 46. Angion Biomedica Business Overview
Table 47. Angion Biomedica Ischemia Reperfusion Injury Product
Table 48. Angion Biomedica Revenue in Ischemia Reperfusion Injury Business (2017-2022) & (US$ Million)
Table 49. Angion Biomedica Recent Development
Table 50. Catalyst Biosciences Company Detail
Table 51. Catalyst Biosciences Business Overview
Table 52. Catalyst Biosciences Ischemia Reperfusion Injury Product
Table 53. Catalyst Biosciences Revenue in Ischemia Reperfusion Injury Business (2017-2022) & (US$ Million)
Table 54. Catalyst Biosciences Recent Development
Table 55. Ischemix Inc Company Detail
Table 56. Ischemix Inc Business Overview
Table 57. Ischemix Inc Ischemia Reperfusion Injury Product
Table 58. Ischemix Inc Revenue in Ischemia Reperfusion Injury Business (2017-2022) & (US$ Million)
Table 59. Ischemix Inc Recent Development
Table 60. Opsona Therapeutics Company Detail
Table 61. Opsona Therapeutics Business Overview
Table 62. Opsona Therapeutics Ischemia Reperfusion Injury Product
Table 63. Opsona Therapeutics Revenue in Ischemia Reperfusion Injury Business (2017-2022) & (US$ Million)
Table 64. Opsona Therapeutics Recent Development
Table 65. Pharming Company Detail
Table 66. Pharming Business Overview
Table 67. Pharming Ischemia Reperfusion Injury Product
Table 68. Pharming Revenue in Ischemia Reperfusion Injury Business (2017-2022) & (US$ Million)
Table 69. Pharming Recent Development
Table 70. TheraSource Company Detail
Table 71. TheraSource Business Overview
Table 72. TheraSource Ischemia Reperfusion Injury Product
Table 73. TheraSource Revenue in Ischemia Reperfusion Injury Business (2017-2022) & (US$ Million)
Table 74. TheraSource Recent Development
Table 75. Bolder Biotechnology Company Detail
Table 76. Bolder Biotechnology Business Overview
Table 77. Bolder Biotechnology Ischemia Reperfusion Injury Product
Table 78. Bolder Biotechnology Revenue in Ischemia Reperfusion Injury Business (2017-2022) & (US$ Million)
Table 79. Bolder Biotechnology Recent Development
Table 80. Corline Biomedical Company Detail
Table 81. Corline Biomedical Business Overview
Table 82. Corline Biomedical Ischemia Reperfusion Injury Product
Table 83. Corline Biomedical Revenue in Ischemia Reperfusion Injury Business (2017-2022) & (US$ Million)
Table 84. Corline Biomedical Recent Development
Table 85. Mifcortx Company Detail
Table 86. Mifcortx Business Overview
Table 87. Mifcortx Ischemia Reperfusion Injury Product
Table 88. Mifcortx Revenue in Ischemia Reperfusion Injury Business (2017-2022) & (US$ Million)
Table 89. Mifcortx Recent Development
Table 90. Balmes Transplantation Company Detail
Table 91. Balmes Transplantation Business Overview
Table 92. Balmes Transplantation Ischemia Reperfusion Injury Product
Table 93. Balmes Transplantation Revenue in Ischemia Reperfusion Injury Business (2017-2022) & (US$ Million)
Table 94. Balmes Transplantation Recent Development
Table 95. NovelMed Therapeutics Company Detail
Table 96. NovelMed Therapeutics Business Overview
Table 97. NovelMed Therapeutics Ischemia Reperfusion InjuryProduct
Table 98. NovelMed Therapeutics Revenue in Ischemia Reperfusion Injury Business (2017-2022) & (US$ Million)
Table 99. NovelMed Therapeutics Recent Development
Table 100. Hope Pharmaceuticals Company Detail
Table 101. Hope Pharmaceuticals Business Overview
Table 102. Hope Pharmaceuticals Ischemia Reperfusion InjuryProduct
Table 103. Hope Pharmaceuticals Revenue in Ischemia Reperfusion Injury Business (2017-2022) & (US$ Million)
Table 104. Hope Pharmaceuticals Recent Development
Table 105. Omeros Corp Company Detail
Table 106. Omeros Corp Business Overview
Table 107. Omeros Corp Ischemia Reperfusion InjuryProduct
Table 108. Omeros Corp Revenue in Ischemia Reperfusion Injury Business (2017-2022) & (US$ Million)
Table 109. Omeros Corp Recent Development
Table 110. Prothix Company Detail
Table 111. Prothix Business Overview
Table 112. Prothix Ischemia Reperfusion InjuryProduct
Table 113. Prothix Revenue in Ischemia Reperfusion Injury Business (2017-2022) & (US$ Million)
Table 114. Prothix Recent Development
Table 115. SBI Pharmaceuticals Company Detail
Table 116. SBI Pharmaceuticals Business Overview
Table 117. SBI Pharmaceuticals Ischemia Reperfusion InjuryProduct
Table 118. SBI Pharmaceuticals Revenue in Ischemia Reperfusion Injury Business (2017-2022) & (US$ Million)
Table 119. SBI Pharmaceuticals Recent Development
Table 120. Angion Biomedica Company Information
Table 121. Angion Biomedica Business Overview
Table 122. Angion Biomedica Ischemia Reperfusion Injury Revenue in Ischemia Reperfusion Injury Business (2019-2024) & (US$ Million)
Table 123. Angion Biomedica Revenue in Ischemia Reperfusion Injury Business (2019-2024) & (US$ Million) Portfolio
Table 124. Angion Biomedica Recent Development
Table 125. Catalyst Biosciences Company Information
Table 126. Catalyst Biosciences Business Overview
Table 127. Catalyst Biosciences Ischemia Reperfusion Injury Revenue in Ischemia Reperfusion Injury Business (2019-2024) & (US$ Million)
Table 128. Catalyst Biosciences Revenue in Ischemia Reperfusion Injury Business (2019-2024) & (US$ Million) Portfolio
Table 129. Catalyst Biosciences Recent Development
Table 130. Ischemix Inc Company Information
Table 131. Ischemix Inc Business Overview
Table 132. Ischemix Inc Ischemia Reperfusion Injury Revenue in Ischemia Reperfusion Injury Business (2019-2024) & (US$ Million)
Table 133. Ischemix Inc Revenue in Ischemia Reperfusion Injury Business (2019-2024) & (US$ Million) Portfolio
Table 134. Ischemix Inc Recent Development
Table 135. Opsona Therapeutics Company Information
Table 136. Opsona Therapeutics Business Overview
Table 137. Opsona Therapeutics Ischemia Reperfusion Injury Revenue in Ischemia Reperfusion Injury Business (2019-2024) & (US$ Million)
Table 138. Opsona Therapeutics Revenue in Ischemia Reperfusion Injury Business (2019-2024) & (US$ Million) Portfolio
Table 139. Opsona Therapeutics Recent Development
Table 140. Pharming Company Information
Table 141. Pharming Business Overview
Table 142. Pharming Ischemia Reperfusion Injury Revenue in Ischemia Reperfusion Injury Business (2019-2024) & (US$ Million)
Table 143. Pharming Revenue in Ischemia Reperfusion Injury Business (2019-2024) & (US$ Million) Portfolio
Table 144. Pharming Recent Development
Table 145. TheraSource Company Information
Table 146. TheraSource Business Overview
Table 147. TheraSource Ischemia Reperfusion Injury Revenue in Ischemia Reperfusion Injury Business (2019-2024) & (US$ Million)
Table 148. TheraSource Revenue in Ischemia Reperfusion Injury Business (2019-2024) & (US$ Million) Portfolio
Table 149. TheraSource Recent Development
Table 150. Bolder Biotechnology Company Information
Table 151. Bolder Biotechnology Business Overview
Table 152. Bolder Biotechnology Ischemia Reperfusion Injury Revenue in Ischemia Reperfusion Injury Business (2019-2024) & (US$ Million)
Table 153. Bolder Biotechnology Revenue in Ischemia Reperfusion Injury Business (2019-2024) & (US$ Million) Portfolio
Table 154. Bolder Biotechnology Recent Development
Table 155. Corline Biomedical Company Information
Table 156. Corline Biomedical Business Overview
Table 157. Corline Biomedical Ischemia Reperfusion Injury Revenue in Ischemia Reperfusion Injury Business (2019-2024) & (US$ Million)
Table 158. Corline Biomedical Revenue in Ischemia Reperfusion Injury Business (2019-2024) & (US$ Million) Portfolio
Table 159. Corline Biomedical Recent Development
Table 160. Mifcortx Company Information
Table 161. Mifcortx Business Overview
Table 162. Mifcortx Ischemia Reperfusion Injury Revenue in Ischemia Reperfusion Injury Business (2019-2024) & (US$ Million)
Table 163. Mifcortx Revenue in Ischemia Reperfusion Injury Business (2019-2024) & (US$ Million) Portfolio
Table 164. Mifcortx Recent Development
Table 165. Balmes Transplantation Company Information
Table 166. Balmes Transplantation Business Overview
Table 167. Balmes Transplantation Ischemia Reperfusion Injury Revenue in Ischemia Reperfusion Injury Business (2019-2024) & (US$ Million)
Table 168. Balmes Transplantation Revenue in Ischemia Reperfusion Injury Business (2019-2024) & (US$ Million) Portfolio
Table 169. Balmes Transplantation Recent Development
Table 170. NovelMed Therapeutics Company Information
Table 171. NovelMed Therapeutics Business Overview
Table 172. NovelMed Therapeutics Ischemia Reperfusion InjuryRevenue in Ischemia Reperfusion Injury Business (2019-2024) & (US$ Million)
Table 173. NovelMed Therapeutics Revenue in Ischemia Reperfusion Injury Business (2019-2024) & (US$ Million) Portfolio
Table 174. NovelMed Therapeutics Recent Development
Table 175. Hope Pharmaceuticals Company Information
Table 176. Hope Pharmaceuticals Business Overview
Table 177. Hope Pharmaceuticals Ischemia Reperfusion InjuryRevenue in Ischemia Reperfusion Injury Business (2019-2024) & (US$ Million)
Table 178. Hope Pharmaceuticals Revenue in Ischemia Reperfusion Injury Business (2019-2024) & (US$ Million) Portfolio
Table 179. Hope Pharmaceuticals Recent Development
Table 180. Omeros Corp Company Information
Table 181. Omeros Corp Business Overview
Table 182. Omeros Corp Ischemia Reperfusion InjuryRevenue in Ischemia Reperfusion Injury Business (2019-2024) & (US$ Million)
Table 183. Omeros Corp Revenue in Ischemia Reperfusion Injury Business (2019-2024) & (US$ Million) Portfolio
Table 184. Omeros Corp Recent Development
Table 185. Prothix Company Information
Table 186. Prothix Business Overview
Table 187. Prothix Ischemia Reperfusion InjuryRevenue in Ischemia Reperfusion Injury Business (2019-2024) & (US$ Million)
Table 188. Prothix Revenue in Ischemia Reperfusion Injury Business (2019-2024) & (US$ Million) Portfolio
Table 189. Prothix Recent Development
Table 190. SBI Pharmaceuticals Company Information
Table 191. SBI Pharmaceuticals Business Overview
Table 192. SBI Pharmaceuticals Ischemia Reperfusion InjuryRevenue in Ischemia Reperfusion Injury Business (2019-2024) & (US$ Million)
Table 193. SBI Pharmaceuticals Revenue in Ischemia Reperfusion Injury Business (2019-2024) & (US$ Million) Portfolio

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings